文献速递慢性肾脏病血液净化与透析

肠道菌群对尿毒症溶质蓄积影响的代谢组学评估

Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
PubMed 文献 · Kidney Int · 2017-04-08

该研究比较无菌与SPF条件下腺嘌呤诱导肾衰竭小鼠的血浆、粪便和尿液代谢组。在183种检测溶质中,11种包括主要尿毒症毒素在无菌肾衰小鼠中显著降低,但无菌肾衰小鼠肾脏损伤更重。菌群既产生有害溶质,又通过短链脂肪酸和氨基酸利用发挥肾保护作用。

要点

  • 11种菌群来源尿毒症溶质在无菌肾衰小鼠中显著降低。
  • 无菌肾衰小鼠出现结肠短链脂肪酸消失和肾脏损伤加重。
  • 菌群来源短链脂肪酸和氨基酸高效利用可能具有肾保护作用。

核心结论

  • 菌群显著贡献有害尿毒症溶质的产生,但无菌生长对CKD进展有不利影响。

研究设计与样本

  • 研究比较腺嘌呤诱导肾衰竭与对照小鼠在无菌或SPF条件下的血浆、粪便和尿液代谢组,采用毛细管电泳飞行时间质谱方法。

主要发现

  • 在183种检测溶质中,11种溶质包括主要尿毒症毒素在无菌肾衰小鼠中显著低于SPF肾衰小鼠。
  • 这11种溶质包括吲哚硫酸盐、对甲酚硫酸盐、苯基硫酸盐、胆酸盐、马尿酸盐、二甲基甘氨酸、γ-胍基丁酸盐、戊二酸盐、2-羟基戊酸盐、三甲胺N-氧化物和乙酰苯胺。
  • 代谢组分析将这些溶质按来源分为完全菌群来源、宿主与菌群共同来源、菌群与膳食成分共同来源三类。
  • 无菌肾衰条件下结肠短链脂肪酸消失、肠道氨基酸利用减少,且肾脏损伤较SPF肾衰小鼠更严重。

临床怎么用

  • 解读尿毒症溶质来源时需考虑菌群贡献,同时关注菌群缺失对CKD进展的不利影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Gut microbiota is involved in the metabolism of uremic solutes. However, the precise influence of microbiota to the retention of uremic solutes in CKD is obscure. To clarify this, we compared adenine-induced renal failure and control mice under germ-free or specific pathogen-free (SPF) conditions, examining the metabolite profiles of plasma, feces, and urine using a capillary electrophoresis time-of-flight mass spectrometry-based approach. Mice with renal failure under germ-free conditions demonstrated significant changes in plasma metabolites. Among 183 detected solutes, plasma levels of 11 solutes, including major uremic toxins, were significantly lower in germ-free mice than in SPF mice with renal failure. These 11 solutes were considered microbiota-derived uremic solutes and included indoxyl sulfate, p-cresyl sulfate, phenyl sulfate, cholate, hippurate, dimethylglycine, γ-guanidinobutyrate, glutarate, 2-hydroxypentanoate, trimethylamine N-oxide, and phenaceturate. Metabolome profiling showed that these solutes were classified into three groups depending on their origins: completely derived from microbiota (indoxyl sulfate, p-cresyl sulfate), derived from both host and microbiota (dimethylglycine), and derived from both microbiota and dietary components (trimethylamine N-oxide). Additionally, germ-free renal failure conditions resulted in the disappearance of colonic short-chain fatty acids, decreased utilization of intestinal amino acids, and more severe renal damage compared with SPF mice with renal failure. Microbiota-derived short-chain fatty acids and efficient amino acid utilization may have a renoprotective effect, and loss of these factors may exacerbate renal damage in germ-free mice with renal failure. Thus, microbiota contributes substantially to the production of harmful uremic solutes, but conversely, growth without microbiota has harmful effects on CKD progression.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Mishima E, Fukuda S, Mukawa C, et al. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach. Kidney Int. 2017. PMID: 28396122. doi:10.1016/j.kint.2017.02.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。